CardioVasc

, Volume 18, Issue 2, pp 32–39 | Cite as

Behandlung der Aorten- und Mitralklappe

Neue Devices zur Reparatur von Herzklappen

  • Tobias Rheude
  • Costanza Pellegrini
  • Albert Markus Kasel
Zertifizierte Fortbildung Schwerpunkt Kardiologie
  • 19 Downloads

Zusammenfassung

Kathetergestützte Verfahren zur Behandlung von Herzklappenerkrankungen haben sich in den letzten Jahren rasant entwickelt. Der prognostische Nutzen einer kathetergestützten Aortenklappenimplantation bei hohem sowie intermediärem operativen Risiko wurde bereits in randomisierten Studien belegt. Aktuell ist ein Trend zur Behandlung von Patienten mit niedrigem Risiko zu verzeichnen. Zudem erleben interventionelle Verfahren zur Behandlung der Mitralklappe eine dynamische Entwicklung.

Literatur

  1. 1.
    Iung B. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231–43CrossRefGoogle Scholar
  2. 2.
    Gaede L, Blumenstein J, Liebetrau C et al. Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J. 2017; https://doi.org/10.1093/eurheartj/ehx688Google Scholar
  3. 3.
    Vahl TP, Kodali SK, Leon MB. Transcatheter Aortic Valve Replacement 2016: A Modern-Day “Through the Looking-Glass” Adventure. J Am Coll Cardiol. 2016;67:1472–87CrossRefGoogle Scholar
  4. 4.
    Frangieh AH, Ott I, Michel J et al. Standardized Minimalistic Transfemoral Transcatheter Aortic Valve Replacement (TAVR) Using the SAPIEN 3 Device: Stepwise Description, Feasibility, and Safety from a Large Consecutive Single-Center Single-Operator Cohort. Structural Heart. 2017;1:169–78CrossRefGoogle Scholar
  5. 5.
    Leon MB, Smith CR, Mack MJ et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374:1609–20CrossRefGoogle Scholar
  6. 6.
    Reardon MJ, Van Mieghem NM, Popma JJ et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017;376:1321–31CrossRefGoogle Scholar
  7. 7.
    Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607CrossRefGoogle Scholar
  8. 8.
    Thyregod HGH, Steinbrüchel DA, Ihlemann N et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol. 2015;65:2184–194CrossRefGoogle Scholar
  9. 9.
    Baumgartner H, Falk V, Bax JJ et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91CrossRefGoogle Scholar
  10. 10.
    Siemieniuk RA, Agoritsas T, Manja V et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ. 2016;354:i5130CrossRefGoogle Scholar
  11. 11.
    Ott I, Greenbaum AB, Schunkert H et al. First use of an expandable sheath and transcaval access for transcatheter Edwards SAPIEN 3 aortic valve implantation. EuroIntervention. 2015;11:782–4CrossRefGoogle Scholar
  12. 12.
    Greenbaum AB, Babaliaros VC, Chen MY et al. Transcaval Access and Closure for Transcatheter Aortic Valve Replacement: A Prospective Investigation. J Am Coll Cardiol. 2017;69:511–21CrossRefGoogle Scholar
  13. 13.
    Frangieh AH, Kasel AM. TAVI in Bicuspid Aortic Valves “Made Easy.” Eur Heart J. 2017;38:1177–81CrossRefGoogle Scholar
  14. 14.
    Dvir D, Webb JG, Bleiziffer S et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312:162–70CrossRefGoogle Scholar
  15. 15.
    Webb JG, Mack MJ, White JM et al. Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry. J Am Coll Cardiol. 2017;69:2253–62CrossRefGoogle Scholar
  16. 16.
    Barbanti M. Avoiding Coronary Occlusion and Root Rupture in TAVI — The Role of Pre-procedural Imaging and Prosthesis Selection. Interv Cardiol Rev. 2015;10:94–7Google Scholar
  17. 17.
    Arsalan M, Walther T. Durability of prostheses for transcatheter aortic valve implantation. Nat Rev Cardiol. 2016;13:360–7CrossRefGoogle Scholar
  18. 18.
    Makkar RR, Fontana G, Jilaihawi H et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med. 2015;373:2015–24CrossRefGoogle Scholar
  19. 19.
    Feldman T, Kar S, Elmariah S et al. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. J Am Coll Cardiol. 2015;66:2844–54CrossRefGoogle Scholar
  20. 20.
    Buccheri S, Capodanno D, Barbanti M et al. A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation. Am J Cardiol. 2017;119:1443–9CrossRefGoogle Scholar
  21. 21.
    Puls M, Lubos E, Boekstegers P et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. 2016;37:703–12CrossRefGoogle Scholar
  22. 22.
    Eleid MF, Whisenant BK, Cabalka AK et al. Early Outcomes of Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification. JACC Cardiovasc Interv. 2017;10:1932–42CrossRefGoogle Scholar
  23. 23.
    Babaliaros VC, Greenbaum AB, Khan JM et al. Intentional Percutaneous Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction During Transcatheter Mitral Valve Replacement: First-in-Human Experience. JACC Cardiovasc Interv. 2017;10:798–809CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  • Tobias Rheude
    • 1
  • Costanza Pellegrini
    • 1
  • Albert Markus Kasel
    • 2
  1. 1.Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum MünchenTechnische Universität MünchenMünchenDeutschland
  2. 2.Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum MünchenTechnische Universität MünchenMünchenDeutschland

Personalised recommendations